Electromed Inc. (ELMD)
23.39
-0.25 (-1.06%)
At close: Mar 28, 2025, 3:59 PM
23.23
-0.66%
After-hours: Mar 28, 2025, 05:16 PM EDT
-1.06% (1D)
Bid | 23 |
Market Cap | 200.1M |
Revenue (ttm) | 60.56M |
Net Income (ttm) | 6.87M |
EPS (ttm) | 0.74 |
PE Ratio (ttm) | 31.6 |
Forward PE | 57.49 |
Analyst | Buy |
Ask | 24.65 |
Volume | 62,635 |
Avg. Volume (20D) | 101,816 |
Open | 23.22 |
Previous Close | 23.64 |
Day's Range | 23.18 - 23.84 |
52-Week Range | 13.74 - 35.56 |
Beta | 0.41 |
About ELMD
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that...
Industry Medical - Devices
Sector Healthcare
IPO Date Aug 13, 2010
Employees 174
Stock Exchange AMEX
Ticker Symbol ELMD
Website https://smartvest.com
Analyst Forecast
According to 1 analyst ratings, the average rating for ELMD stock is "Buy." The 12-month stock price forecast is $38, which is an increase of 62.50% from the latest price.
Stock ForecastsNext Earnings Release
Electromed Inc. is scheduled to release its earnings on May 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+13.97%
Electromed shares are trading following a Q2 EPS b...
Unlock content with
Pro Subscription
7 months ago
-6.54%
Electromed shares are trading lower after the company reported worse-than-expected Q4 revenue results.